furosemide has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, S; Corless, CL; Kelly, FJ; Kennefick, TM; Kurtzberg, L; Ledbetter, SR; Oyama, TT; Pratt, BM; Roman, RJ; Thompson, MM | 1 |
| Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishio, M; Ohtani, T; Sakata, Y; Yamamoto, K; Yoshida, J | 1 |
2 other study(ies) available for furosemide and transforming growth factor beta
| Article | Year |
|---|---|
Acute and chronic renal effects of recombinant human TGF-beta2 in the rat.
Topics: Analysis of Variance; Animals; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Furosemide; Hemodynamics; Infusions, Intravenous; Kidney; Kidney Function Tests; Laser-Doppler Flowmetry; Male; Organ Size; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Reference Values; Renal Circulation; Transforming Growth Factor beta | 1999 |
Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.
Topics: Animals; Echocardiography; Furosemide; Heart Failure; Interleukin-1; Norepinephrine; Rats; Rats, Inbred Dahl; RNA, Messenger; Sodium Chloride, Dietary; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides; Survival Rate; Transforming Growth Factor beta; Treatment Outcome; Ventricular Remodeling | 2005 |